Woodline Partners’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-182,564
Closed -$10.6M 1013
2024
Q3
$10.6M Buy
182,564
+91,006
+99% +$4.47M 0.09% 285
2024
Q2
$3.71M Sell
91,558
-12,417
-12% -$492K 0.04% 370
2024
Q1
$4.37M Buy
+103,975
New +$4.06M 0.04% 373

Other funds holding ASTH

Woodline Partners's ASTH Position: Q4 2024 in Review

Woodline Partners sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 182,564 shares — an estimated $10.6M sold.

Woodline Partners first reported a position in ASTH in Q1 2024 and held it in 3 quarters. The position peaked at $10.6M in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Woodline Partners reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Woodline Partners sold 182,564 Astrana Health shares in Q4 2024, an estimated $10.6M.
  • Woodline Partners first reported a position in Astrana Health in Q1 2024 and held it in 3 quarters.
  • Woodline Partners's Astrana Health position peaked at $10.6M in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.